GC녹십자웰빙 breaks ground on medical device GMP plant in Eumseong, South Korea

GC녹십자웰빙 held a groundbreaking ceremony on November 2, 2026 for a new medical device GMP plant in Eumseong, Chungcheongbuk-do, South Korea. The facility will produce fillers and skin boosters with an annual capacity of up to 3 million units, with completion targeted for Q2 2027.

“이번 착공은 단순한 생산시설 확충을 넘어 메디컬 에스테틱 사업의 지속적인 성장을 위한 중요한 출발점”nanumy.co.kr

• 1 source
• nanumy.co.krGC녹십자웰빙, 의료기기 GMP 공장 착공…필러·스킨부스터 연 300만개 생산 < 보도자료 < 기사본문 - 나눔경제뉴스이경여 기자Nov 4, 2026

Summarized from public sources; check the original articles before acting on it.